General discussion, page-7734

Strictly speaking they are not a competitor and that will become increasingly apparent, LOL.
But this space is still sufficiently undifferentiated that the unsophisticated investor will consider both companies as sharing a single sphere of operations. 'Cannabis stocks'.

Also good to remember we've only just recently pulled the trigger on shutting down our oil sales operations, to focus exclusively on our global drug development programs. Excellent choice, but it will take a little while for our local market to catch up and realize we belong in one category, and one category only: bio tech. This is the beauty of having made the call to cease those operations prior to presenting US and Middle Eastern investors, and listing on the NASDAQ. We will start out correctly categorized there, from the word GO. It will greatly assist in making clear Incannex is in an entirely different league, compared to the other company we've alluded to here.